| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $126.2M | +61.3% |
| SG&A Expense | $41.0M | +72.4% |
| Operating Income | -$167.2M | -63.9% |
| Pre-tax Income | -$152.1M | -58.5% |
| Income Tax | $1K | +0.0% |
| Net Income | -$152.1M | -58.5% |
| EPS (Basic) | -$2.75 | -22.2% |
| EPS (Diluted) | -$2.75 | -22.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.6M | +102.8% |
| Short-term Investments | $548.2M | +376.6% |
| Current Assets | $651.2M | +278.6% |
| Total Assets | $655.7M | +273.5% |
| Current Liabilities | $25.4M | +13.8% |
| Long-term Debt | $50.7M | +1.6% |
| Total Liabilities | $78.5M | +6.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$134.7M | -46.1% |
| Capital Expenditures | $972K | +1442.9% |
| Investing Cash Flow | -$425.0M | -977.9% |
| Financing Cash Flow | $606.7M | +354.3% |
| Free Cash Flow | -$135.7M | -47.1% |
| Stockholders' Equity |
| $577.2M |
| +467.6% |